Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences business

TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industryThe company serves blue-chip clients in Europe TTP Group employs 1,000 people across 27 locations under the operational brands Pharmaplan and TriplanExyte CEO Büchele: "With the acquisition of TTP, Exyte expands its position as a global player in the pharma market, strengthening its footprint in Europe."
www.exyte.net 

View original content:https://www.prnewswire.co.uk/news-releases/exyte-acquires-ttp-group-to-accelerate-growth-of-biopharma-and-life-sciences-business-302239012.html

en | boerse | 67929067 |